Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy. This comprehensive view of CAR T-cell therapy will give blood cancer […]
Attacking the Cancer Cell: Advances in CAR T-Cell Therapy Read More »
Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her long journey through multiple cancer treatments, which eventually led to CAR T-cell therapy and complete remission. Hear one patient’s story of hope, as new treatments continued to come out, keeping her stable until the one
Statistics Don’t Color My Outcome: A CAR T-cell Therapy Success Read More »
Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses current treatments for chronic lymphocytic leukemia (CLL) and the exciting possibilities for the future using immunotherapies. Dr. Davids shares how the goal of treatment is long term remission and quality of life. Since 2010, BTK
Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL) Read More »
Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part Two of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the development and utilization of CAR T-cell therapy for MCL. Approved in July of 2020 for relapsed or refractory MCL, CAR T-cell therapy has
Mantle Cell Lymphoma (MCL) Part Two: CAR T-Cell Therapy Read More »
Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). In this episode, Charles tells us about his treatment for AML, participation in clinical trials, and shares about his struggle to find a bone marrow donor as an Asian Pacific Islander. Charles then turned his
Patient-Doctor Perspectives: Hope in the Uncertainty of AML Read More »
Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. In this episode, Dr. Wang delves into the rare blood cancer, blastic plasmacytoid dendritic cell neoplasm (BPDCN). Usually identified by characteristic deep purple lesions, oncologists continue to raise
Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Read More »
Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. In this episode, we speak to Dr. Larry Saltzman, a Chronic Lymphocytic Leukemia (CLL) survivor and physician researcher and Dr. Steven Coutre from Stanford Medicine. Dr. Larry shares his experience living with
Patient-Doctor Perspectives: CLL and a Decade of Transformation Read More »
Join us as we speak to Dr. Caron Jacobson, an Assistant Professor of Medicine at Harvard Medical School and a lymphoma physician and researcher at the Dana-Farber Cancer Institute. In this episode, Dr. Jacobson shares about the use and benefits of CAR T-cell therapy in B-cell cancers, such as diffuse large B-cell lymphoma (DLBCL), mantle
How CAR T-cell Therapy Gives Hope to Cancer Patients Read More »
Join us as we report on the latest developments in immunotherapy from the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition that was hosted virtually December 5-8, 2020. In this episode, we will be speaking to Dr. Laurie Sehn, a Clinical Professor and Researcher with the British Columbia Cancer Centre for Lymphoid Cancer
Tackling Lymphoma: Recent Advances in Immunotherapy Read More »
They say hindsight is always 20/20. Looking back, Tim Card remembers how his body may have been sending signals that something was wrong, but how he often attributed them to his active and busy lifestyle. Tim received his shocking lymphoma diagnosis after logging onto his medical portal, while awaiting test results. Tim is Penn State Cancer Institute’s first chimeric antigen
“The Only Way Through It, Is Through It”: Tim Card’s Story Read More »
On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was diagnosed in early 2016 when he underwent 7 months of chemotherapy which put his cancer into temporary remission. Unfortunately, 7 months later, it returned in a more aggressive form. With options dwindling, he was accepted
How CAR T-cell Therapy Saved My Life: Chuck’s Story Read More »
On this episode, Alicia and Lizette speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist at Texas Children’s Cancer Center where she is a member of the Leukemia and Bone Marrow Transplant programs. She works as part of The Center for Cell and Gene Therapy at Baylor College of Medicine,
CAR T-cell Explained: Recovering from CAR T-cell Therapy Read More »
Join Alicia and Lizette as they speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist at Texas Children’s Cancer Center where she is a member of the Leukemia and Bone Marrow Transplant programs. Specifically, she works as part of a research program called The Center for Cell and Gene Therapy
CAR T-cell Therapy Explained: What Is It and How Does It Work? Read More »
Like any therapy that is administered in oncology, there is great promise but also, unfortunately, several toxicities and side effects that must be understood and monitored. Join Alicia and Lizette as they speak with Dr. Jonathon B. Cohen, an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine
CAR T-Cell Therapy Explained: Understanding Potential Side Effects Read More »